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A B S T R A C T
Due to a combination of ecological, political, and demographic factors, the emergence of novel pathogens has
been increasingly observed in animals and humans in recent decades. Enhancing global capacity to study and
interpret infectious disease surveillance data, and to develop data-driven computational models to guide policy,
represents one of the most cost-effective, and yet overlooked, ways to prepare for the next pandemic.
Epidemiological and behavioral data from recent pandemics and historic scourges have provided rich oppor-
tunities for validation of computational models, while new sequencing technologies and the ‘big data’ revolution
present new tools for studying the epidemiology of outbreaks in real time. For the past two decades, the Division
of International Epidemiology and Population Studies (DIEPS) of the NIH Fogarty International Center has
spearheaded two synergistic programs to better understand and devise control strategies for global infectious
disease threats. The Multinational Influenza Seasonal Mortality Study (MISMS) has strengthened global capacity
to study the epidemiology and evolutionary dynamics of influenza viruses in 80 countries by organizing inter-
national research activities and training workshops. The Research and Policy in Infectious Disease Dynamics
(RAPIDD) program and its precursor activities has established a network of global experts in infectious disease
modeling operating at the research-policy interface, with collaborators in 78 countries. These activities have
provided evidence-based recommendations for disease control, including during large-scale outbreaks of pan-
demic influenza, Ebola and Zika virus. Together, these programs have coordinated international collaborative
networks to advance the study of emerging disease threats and the field of computational epidemic modeling. A
global community of researchers and policy-makers have used the tools and trainings developed by these pro-
grams to interpret infectious disease patterns in their countries, understand modeling concepts, and inform
control policies. Here we reflect on the scientific achievements and lessons learnt from these programs (h-
index= 106 for RAPIDD and 79 for MISMS), including the identification of outstanding researchers and fellows;
funding flexibility for timely research workshops and working groups (particularly relative to more traditional
investigator-based grant programs); emphasis on group activities such as large-scale modeling reviews, model
comparisons, forecasting challenges and special journal issues; strong quality control with a light touch on
outputs; and prominence of training, data-sharing, and joint publications.
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1. Background
In 2018 the Fogarty International Center celebrates its 50th year
(1968–2018) as the only part of the US National Institutes of Health
focused singularly on global health. The Fogarty International Center
(FIC) uses high return-on-investment approaches to maximally impact
global health, including (a) establishing strong international colla-
borative research networks, (b) building capacity for research in low-
and middle-income countries (LMICs) through training, and (c) liaising
with a wide range of other US government agencies and private part-
ners with a shared interest in advancing global health. Here, we de-
scribe two flagship FIC-led programs that identified critical gaps in
infectious disease research and formed global networks of researchers
to address the scientific questions most needed to inform policy and
outbreak response.
The 2001 foot-and-mouth disease outbreak in the UK, the 2009
influenza A/H1N1 pandemic, and the 2013–2016 epidemic of Ebola in
West Africa underscore the continual threat of emerging and re-emer-
ging acute infections. Knowledge of the mode of spread of a pathogen
and the subpopulations at highest risk of transmitting the pathogen and
experiencing severe disease can inform key decisions about social dis-
tancing and prioritization of therapeutics and vaccines. Designing dis-
ease models rooted in empirical data, enhancing existing tools for data
analysis, and teaching collaborators around the world how to apply
these tools represent highly cost-effective ways to prepare for the next
infectious disease outbreak. Past disease events have highlighted the
capabilities of infectious disease modeling and molecular epidemiology
to effectively guide outbreak responses, but also revealed persistent
challenges in making predictions in data-scarce and rapidly changing
field settings (Woolhouse, Chase-Topping et al. 2001; Keeling,
Woolhouse et al. 2003; Heesterbeek, Anderson et al. 2015; Woolhouse,
Rambaut et al. 2015; Dudas, Carvalho et al. 2017).
The increasing availability of large, electronic datasets, or “big
data,” presents new opportunities for scientists to understand drivers of
disease. Electronic health records, social media, satellite imagery, and
cell phone records provide highly granular information on human be-
havior, the environment, transmission patterns, and disease burden
(Lazer, Kennedy et al. 2014; Bansal, Chowell et al. 2016; Simonsen
et al., 2016). Recent advances in next-generation sequencing techniques
have markedly increased the amount of pathogen genetic data available
for study, providing almost real-time insights into how pathogens from
different locations are genetically related and infer transmission pat-
terns (Dudas, Carvalho et al. 2017). Increasingly, researchers are de-
vising methods to collect data even in resource-limited settings. The
highly portable MinION sequencer demonstrated how real-time whole-
genome sequence data could be generated in remote locales during the
Zika epidemic (Quick, Loman et al. 2016; Faria, Quick et al. 2017).
Mobile phone records and remotely-sensed nightlights present addi-
tional strategies to track human movements and contacts in resource-
limited settings (Bharti, Tatem et al. 2011; Wesolowski, Eagle et al.
2012; Wesolowski et al., 2016b).
Since its inception in 2001, the Division of International
Epidemiology and Population Studies (DIEPS) has played a central role
in promoting the growth of a vibrant and multi-disciplinary infectious
disease modeling community through its MISMS and RAPIDD pro-
grams. Together, these programs have strengthened infectious disease
modeling on a global scale by developing research and training net-
works, facilitating collaboration and data sharing, developing and dis-
seminating new methodologies, and building a stronger collective voice
for evidence-based policymaking. Most critically, these programs have
been catalysts for other larger US agencies and governments worldwide
to expand support for infectious disease modeling research and to in-
corporate models into policy decision-making.
2. MISMS: multinational influenza seasonal mortality study
2.1. Building global capacity in computational influenza research
The MISMS project was initiated in 2001 to build global research
capacity for the study of influenza viruses using computational methods
(http://misms.net, Box 1). The acronym originally referred to the
Multinational Influenza Seasonal Mortality Study, although the pro-
gram quickly expanded beyond mortality studies. MISMS has a mission
to promote research, training and inform policy, more specifically (i) to
characterize the global epidemiological and evolutionary dynamics of
influenza in different host species, and (ii) to empower influenza re-
searchers globally to study influenza and inform policymaking in their
own countries. Towards this end, 18 technical training workshops were
conducted on six continents during 2007–2018. These workshops focus
on reviewing the state of influenza research and epidemiology in dif-
ferent global regions, and hands-on teaching of time series analysis of
contemporary and historical outbreaks, control measures, mathema-
tical transmission models, and phylogenetic approaches (Fig. 1). MISMS
supports interdisciplinary approaches by fostering collaborations be-
tween historians, demographers, ecologists, evolutionary biologists,
vaccine manufacturers, microbiologists, epidemiologists, and policy-
makers, as evidenced by the rich diversity of publications (Fig. 2).
2.2. Addressing research gaps in low-income countries
None of the last three pandemics – influenza A/H2N2 in 1957, A/
H3N2 in 1968, and A/H1N1 in 2009 – originated in a high-income
country. Building capacity for influenza research in low- and middle-
income countries is an essential but underfunded part of global pan-
demic preparedness and a key goal of the MISMS program. A central
feature of MISMS workshops has been partnership with local organi-
zations to help identify talented scientists in under-resourced settings.
Workshops are held either in low- or middle-income countries, or the
program provides funding for researchers from these countries to attend
workshops in high-income countries (Box 1). The 2009 MISMS work-
shop in Dakar, Senegal, was co-organized with Institut Pasteur and was
the first influenza workshop ever held in Africa. In addition to periodic
workshops that provide intense short-term training to 30–100 partici-
pants, MISMS staff also host junior and mid-career researchers from
Central America, Europe, Africa, and Asia for further training at the
NIH for periods ranging from a few months to several years. These
scientists gain deep expertise in epidemiological and phylogenetic ap-
proaches and establish research programs to inform policy in their
home countries.
2.3. New vaccination strategies
Organizing workshops in under-studied tropical settings brought
critical attention to the burden of influenza and the variability of sea-
sonal patterns in less connected locales and warm, humid climates
(Tamerius et al., 2011; Bloom-Feshbach, Alonso et al. 2012). Increased
recognition of the global burden of influenza in tropical and semi-tro-
pical regions also has encouraged uptake of routine annual vaccination
in many middle-income countries. However, several MISMS studies
rooted in epidemiological and virological data have pointed out that the
semi-annual schedule is designed for wealthier countries in the tem-
perate regions in the Northern and Southern hemispheres, and are
suboptimal for many tropical countries that experience influenza at
different times of the year, or have multiple peaks (Alonso et al., 2007;
de Mello, de Paiva et al. 2009; Tamerius et al., 2011; Bloom-Feshbach,
Alonso et al. 2012; Green, Andrews et al. 2013; Alonso et al., 2015a,b;
Ayora-Talavera, Flores et al. 2017). MISMS research has informed
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whether a tropical country should opt for the Northern or Southern
hemisphere vaccine formulation – or in some cases both. Large coun-
tries with heterogenous influenza patterns and climate, such as China,
Mexico and Brazil, may require different vaccine recommendations for
their northern and southern regions (Alonso et al., 2007; de Mello, de
Paiva et al. 2009; Ayora-Talavera, Flores et al. 2017). Additionally,
MISMS research demonstrating the low impact of senior vaccination
programs in the US and Italy paved the way for expanded vaccination
Box 1
Why have RAPIDD and MISMS workshops been so successful?
Since 2007, RAPIDD has sponsored 118 workshops on topics ranging from gain-of-function experiments to the latest developments in particle
filtering methods. These workshops have had a remarkable track record of enabling constructive syntheses of current frontiers in the science of
disease modeling, and in spurring innovation and analysis of case studies to advance those frontiers. They also have earned a strong reputation
in the field as important venues for scientific discourse. Here we summarize distinctive elements of those workshops that we believe have
contributed to their success.
• Lightweight and nimble proposal process, steered by two generous and visionary scientists that had deep expertise in the field. The program
‘let a thousand flowers bloom’ by accepting workshop proposals on a rolling basis with a two-page initial proposal. For promising proposals,
program leadership then iterates with proposers to refine the focus on RAPIDD goals, ensure solid deliverables, and optimize the participant
list.• Small size and balanced composition. Research workshops are generally kept to 10–20 participants, to ensure free-flowing and natural
discussion. Age structure is key, with emphasis on including junior scientists (especially postdocs) so there are people with the time and
incentive to do follow-up work.• Flexible structure. Adapt meeting structure to meet scientific needs. Some workshops focus on conceptual or methodological issues, others on
particular disease systems. Some of the best workshops had a central theme combined with data in hand and time to analyze it.• Keep workshops short (typically 1.5–3 days) and maximize the value of in-person meetings. Pre-workshop teleconferences (among leaders or
the whole group) help to reach consensus on goals and scope, so talks are on target and preliminary work can get done. Avoid overloading
the schedule with formal talks, to ensure ample time for discussion and breakout groups; some participants can act as synthesizers or
reactors rather than giving talks. Relaxed interactions on a hike or at a pub usually pay off.• Designed for follow-through. Before the meeting, specify deliverable and timelines, and identify who will lead these efforts (often RAPIDD
postdocs or workshop organizers). Get key pieces such as data sets and foundational analyses in place beforehand. Require workshop
reports within a few months, summarizing the scientific content of the meeting, progress toward deliverables, and new opportunities that
have emerged. Support follow-up when warranted, including ‘working meetings’ of project leaders, but also be prepared to stop threads
that are not productive or not aligned with program priorities.
Since 2005, MISMS has convened 18 training workshops on all 5 continents and trained several hundreds of scientists on computational
methods for infectious diseases. The unique characteristics of these workshops include:
• The primary output of these workshops is technology transfer; i.e. capacity building in infectious disease analytics. Participants are not
expected to become modeling experts after a short workshop, but instead they should understand principles of data analysis and modeling
(to the point that they are able to understand a disease modeling article).• MISMS workshops are typically regionally-focused and organized in tandem with a local university, research institute, or ministry of health.
Regional participants are identified based on an exhaustive PubMed search (especially in early years of the MISMS program), word-of-
mouth, and existing MISMS contacts (particularly as the program matured). Public health experts from WHO, CDC, and local institutions,
are always invited.• Workshops are sometimes organized in conjunction with a larger influenza scientific meeting to decrease travel costs and optimize parti-
cipation.• Weeklong workshops include 2 days of general scientific session and 3 days of hands-on training. The general session is meant to expose the
state of the art of influenza epidemiology in the region and highlight success stories in influenza modeling and MISMS collaborations. The
hands-on training session demonstrate methods in time series analysis, transmission models, and evolutionary analyses.• Workshops are open to scientists and public health experts who do not have prior training in infectious disease modeling, e.g. veterinarians,
clinicians, virologists, lab technicians, policy makers, etc.• Flexible travel support for participants based on abstract selection process; focus on participants bringing data that may be amenable to
modeling, those who have a clear training plan, and those from underserved areas.• Training portion of the workshop is limited to 30 participants, for 5–8 faculty, to facilitate one-on-one interactions.• Participants are encouraged to bring their own data; at least a day is devoted to small-group analyses of these data. Sample datasets are
always available for demonstration purposes and for those unable to bring data (or with sparser datasets).• While the workshops are focused on influenza, participation is open to scientists working on related infectious diseases, recognizing that
relevant (or specific) influenza data may be scarce in some countries, and that computational skills are cross-cutting.• Workshop deliverables include joint publications and supplementary issues that spur collaborative work (for instance, Supplementary issues
on Big Data for Infectious Disease Surveillance or Historical Pandemics (Simonsen, Viboud et al. 2011; Bansal, Chowell et al. 2016;
Simonsen et al., 2016))• Similarly to RAPIDD, there is opportunity for follow-up beyond the workshop, primarily via longer visits to NIH for more extensive training
with MISMS staff, and occasionally, through remote collaborations. Workshops can also be organized in the same region a few years later to
gauge progress. MISMS staff provides support for completion of analytical work and manuscripts, where workshop participants are re-
cognized as first authors.
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programs targeted at children who are important foci of transmission
(Simonsen et al., 2003; Simonsen, Reichert et al. 2005; Rizzo, Viboud
et al. 2006; Simonsen et al., 2009). Global vaccine strategies also re-
quire an understanding of how viruses migrate long distances between
countries, and how viruses evolve antigenically to require vaccine
strain updates (Ferro, Budke et al. 2010; Adler, Eames et al. 2014).
Active areas of MISMS research include a deeper understanding of in-
fluenza migration pathways at different spatial scales, climatic and
demographic drivers of influenza seasonality, and the mapping between
vaccine match and population-level protection, all of which can affect
vaccine policy (Box 2).
2.4. Pandemic preparedness
The global network of collaborators that grew out of the MISMS
program is a unique resource to leverage in the event of the next
pandemic influenza or another infectious disease threat. As a case in
point, in 2009, the presence of MISMS-trained researchers in Mexico
facilitated early reporting of severity and striking age-shifts in mortality
patterns that are signatures of new pandemic viruses (Chowell et al.,
2009a, 2009b, 2009c, Miller, Viboud et al. 2009). During the critical
early stages of the pandemic, rapid reporting of these epidemiological
patterns informed use of limited resources, including vaccine and
Fig. 1. Map of MISMS research and training workshops (n=17, 2007–2018, top), and MISMS collaborations (bottom).
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therapeutics, as well as interventions such as school closures (Chowell
et al., 2009a, 2009b, 2009c, Chowell, Echevarria-Zuno et al. 2011).
MISMS collaborations also focus on “archeo-epidemiology” studies, or
studies of past influenza pandemics and other historic scourges
(Simonsen et al., 2011). Such studies have provided estimates of in-
fluenza transmission intensity, age-structured mortality patterns,
spatial dynamics, and the distribution of mortality across multiple
pandemic waves as far back as the 1880s (Andreasen, Viboud et al.
2008; Bloom-Feshbach et al., 2011; Simonsen et al., 2011). Quantita-
tive studies of past patterns can help predict the course of future pan-
demics and inform the range of plausible scenarios for preparedness,
including elevated mortality occurring several years after the initial
Fig. 2. Maps of MISMS and RAPIDD collaborators, based on bibliometric analysis. Left: MISMS. Right: RAPIDD. Bibliometric data collection performed July 1, 2018.
Box 2
Policy impact of RAPIDD and MISMS: select success stories.
• Vaccination: MISMS studies in large and climatologically-diverse countries have identified geographic differences that affect annual in-
fluenza vaccination programs. Because of the timing of influenza epidemics and composition of circulating strains in Southern China and
Southern Brazil, Southern provinces should use the Southern Hemisphere influenza vaccine, while the Northern part of these countries
should use the Northern Hemisphere vaccine (Miller, Viboud et al. 2008; Chowell, Viboud et al. 2009; Yu, Alonso et al. 2013; Alonso et al.,
2015a,b).• Surveillance: MISMS work on the phylodynamics of swine influenza viruses highlight the importance of undersampled “source” locations
with large pig populations and intense swine flows to other regions, such as Russia. Surveillance efforts should target these regions that are
expected to generate important global diversity of swine viruses (Nelson, Viboud et al. 2015).• Pandemic control measures: Mexico implemented nationwide social distancing measures to control the 2009 influenza pandemic (combi-
nation of mandatory school closure, restaurant closure, and cancellation of large gatherings) during an 18-day period in late April and early
May 2009. MISMS researchers were among the first to work with the ministry of health to assess the dynamics of the outbreak and the
impact of interventions. By fitting transmission models to surveillance data, they found that social distancing reduced influenza trans-
mission by one-third, lending support to these costly measures. Beyond the 2009 pandemic, this works suggests that social distancing
interventions could be implemented to mitigate severe outbreaks and alleviate the pressure on healthcare, for limited periods of time and
until other interventions (such as vaccination) can kick in (Chowell, Bertozzi et al. 2009; Chowell, Viboud et al. 2009; Chowell, Echevarria-
Zuno et al. 2011, 2012).• Addressing data gaps: On the RAPIDD front, modelers thought creatively to find ways to fill data gaps that were essential obstacles to
resolving policy-relevant health problems. For example, a common problem in livestock diseases is the lack of information on farm lo-
cations and animal movements, especially in the US. These are key ingredients to design transmission models, evaluate interventions, and
help prepare for potential outbreaks such as Foot-and-Mouth disease. The RAPIDD network designed a method to leverage veterinary
records and mandatory licenses filed by farmers. Further, much simulation work was done based on the richer UK dataset informing farm
locations, animal movements, and observed Foot-and-Mouth disease outbreaks, to strengthen US models and remedy data gaps.• Gain-of-function studies and pandemic risk prediction: As the debate on gain-of-function studies intensified, RAPIDD organized a two-
workshop series on “Assessing the outbreak potential of nonhuman influenza viruses using sequence-based risk approaches’” and “Modeling
and Predicting Influenza Phenotypes” to explore modeling of pandemic potential. Gain-of-function studies indicated that an avian influenza
virus undergies a series of genetic changes for human adaptation, which are required for efficient transmission among mammals. The
workshops assembled global experts to synthesize current knowledge about the three key steps of the adaptation process: switch of the
hemagglutinin surface protein to mammalian alpha-2,6 sialic acid binding, enhancement of pH- and temperature-dependent stability of the
hemagglutinin, and adaptation of the viral polymerase to function in mammalian cells. These workshops spurred modeling work to infer
pandemic potential based on ferret transmission experiments, and further work is underway to explore whether mapping of genotype-to-
phenotype traits is possible, despite rampant epistatic interactions across the influenza genome (Buhnerkempe et al., 2015a). Other avenues
for policy-oriented research include the optimization of global influenza surveillance strategies to identifies early precursors of pandemic
strains.• Vaccination decline in the aftermath of Ebola: Another example of the link between RAPIDD research and policy is a study on the precipitous
decline in childhood immunization during the 2014–2015 Ebola outbreak (Takahashi et al., 2015). RAPIDD modelers estimated that
around one million children in Liberia, Sierra Leone and Guinea were vulnerable to measles following the suspension of vaccination
campaigns during the Ebola outbreak. The study concluded on the urgent need to mount an aggressive vaccination campaign as soon as the
Ebola outbreak subsided. This advice was heeded by public health authorities, as measles vaccination campaigns targeting several million
children were launched in Sierra Leone and Guinea in October 2015 and in Liberia a few months earlier.
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emergence of a pandemic virus (Box 2). MISMS also has worked ac-
tively to bridge human and veterinary research communities and un-
derstand the emergence of pandemic viruses at the animal-human in-
terface. Two workshops held in Ames, Iowa, USA, in collaboration with
US Department of Agriculture, focused on swine influenza, while an-
other held in Padua, Italy, in collaboration with Istituto Zooprofilattico
Sperimentale delle Venezie, focused on avian influenza, providing
training opportunities in an active area of influenza research.
2.5. Molecular epidemiology
Improvements to genetic sequencing technologies have reduced
costs worldwide and advanced the field of ‘phylodynamics’, in which
epidemiological dynamics are inferred from pathogen sequence data. In
the early 2000s, new computational packages, including Bayesian
Evolutionary Analysis Sampling Trees (BEAST), provided the capacity
to infer detailed evolutionary, demographic and spatial patterns from
sequence data (Lemey et al., 2009a,b; Lemey, Rambaut et al. 2010).
However, in-depth studies of influenza virus evolution require large
numbers of viral sequences carefully sampled over time and space,
which are unavailable in many low- and middle-income countries. To
address this gap, Fogarty’s MISMS staff partnered with the National
Institute of Allergy and Infectious Diseases (NIAID) and National Li-
brary of Medicine (NLM), to provide whole-genome sequencing of in-
fluenza virus collections free of cost via the Influenza Genome Se-
quencing Program (Box 3). When this sequencing project began in
2005, there were fewer than 100 complete influenza virus genomes
available on GenBank. As of 2017, almost 20,000 influenza virus gen-
omes have been sequenced through this project and made publicly
available. A strong linkage between the Influenza Genome Sequencing
Program and Fogarty’s MISMS network of global researchers, and their
viral collections, has helped address important gaps in influenza se-
quence availability and in turn transmission dynamics. The program
targeted understudied aspects of influenza virus evolution, including
large regions of the viral genome not typically sequenced, under-sam-
pled populations in tropical settings, influenza B virus, and non-human
mammalian hosts (Box 3). The program fostered a global culture of
data-sharing that facilitates large-scale comparative studies across
subtypes, regions, and species, advancing our fundamental under-
standing of influenza virus evolution and ecology.
2.6. Future of MISMS
Despite increased availability of influenza genetic and epidemiolo-
gical data, there are still important gaps, particularly regarding sur-
veillance in Africa and South America and at the animal-human inter-
face (Viboud, Nelson et al. 2013), and poor integration of different data
streams (e.g., epidemiological, antigenic and genetic information), re-
presenting target areas of future MISMS efforts. Because influenza is
unique in combining long-term pandemic risk with a continued need for
annual vaccine updates to reduce the burden of seasonal influenza, the
field has traditionally enjoyed far better attention than other re-
spiratory infections. As genomic and epidemiological data for other
respiratory pathogens increases, a natural extension for MISMS would
be to broaden its scope beyond that of influenza. Recognizing this po-
tential, MISMS collaborators have embarked on modeling studies of
pneumococcus and respiratory syncytial virus, and their interactions
with influenza (Weinberger, Simonsen et al. 2012; Shrestha, Foxman
et al. 2013; Weinberger, Harboe et al. 2014; Shrestha, Foxman et al.
2015; Weinberger, Klugman et al. 2015). With additional resources, a
more systematic broadening of the scope of the MISMS study to other
important human respiratory pathogens would provide fresh opportu-
nities to enhance understanding of multiple disease systems while
drawing on an established global research network and a wealth of
computational tools.
3. RAPIDD: research and policy in infectious disease dynamics
3.1. A disease modeling network to inform policy
Development of infectious disease models deeply rooted in em-
pirical data can improve planning for, and response to, infectious dis-
ease threats; however, the link between modeling groups and policy
makers remains tenuous in many countries (Heesterbeek, Anderson
Box 3
The Influenza Genome Sequencing Project, a large-scale collaboration between NIH institutes and J. Craig Venter Institute, transforms our under-
standing of influenza virus evolution.
1 Major ‘jumps’ in influenza antigenic space can be produced by genomic reassortment events (Holmes, Ghedin et al. 2005; Nelson et al.,
2008a).
2 Multiple lineages of influenza virus are introduced into single geographic locations every winter and co-circulate (Nelson et al., 2007,
2008b).
3 Influenza viruses migrate continuously between winter epidemics in Northern and Southern hemispheres, and the irregular seasonality of
influenza in tropical regions may be central to the virus’s long-term persistence (Nelson et al., 2007; Rambaut, Pybus et al. 2008).
4 The sudden global emergence of influenza A/H3N2 viruses resistant to adamantine drugs was driven by reassortment and genetic hitch-
hiking, and local, but not global, drug selection pressure (Simonsen, Viboud et al. 2007; Nelson et al., 2009).
5 Avian influenza viruses do not transmit as conserved genome constellations, owing to ongoing genomic reassortment and shuffling of genes
(Dugan, Chen et al. 2008).
6 Next-generation sequencing techniques reveal the extent of intra-host diversity, and how sub-populations fluctuate over the course of an
infection and during transmission events. (Ghedin, Fitch et al. 2009; Hughes, Allen et al. 2012)
7 Remarkable spatial fluidity was observed during the 2009 H1N1 pandemic, to the extent that college students with illness on the same day in
the same dorm possessed genetically different viruses, highlighting the challenge of viral control during outbreaks (Holmes, Ghedin et al.
2011).
8 The evolutionary history of influenza A viruses includes a selective sweep of the internal genes of avian influenza viruses during the late
1800s, which may coincide with an invasion of an H7 virus of equine origin (Worobey, Han et al. 2014).
9 Decades of long-distance swine trade has spread viruses between continents, creating multiple niches with high genetic diversity where novel
pandemic viruses may evolve, exemplified by Mexico, the source of the 2009 H1N1 pandemic (Nelson, Lemey et al. 2011; Nelson, Viboud
et al. 2015)
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et al. 2015; Metcalf, Edmunds et al. 2015). Fogarty played an important
role in promoting the field of modeling population-based impact of
biological threats within the U.S. government. Immediately following
the events of September 11th, 2001 and before the anthrax-laced letters
that began just one week later, DIEPS helped establish intergovern-
mental networks to model and address biological threats. These efforts
contributed to launch an extramural modeling funding program on
Models of Infectious Disease Agents (MIDAS) managed by the NIH
National Institute of General Medical Studies and nascent funding to
NIH Fogarty to study bioterror threats. In 2007, the RAPIDD program
was established with funds from the Department of Homeland Security
to build a hub-and-spokes network of infectious disease modelers
working at the interface of policy and academic research, in close col-
laboration with government. The program’s mandate was to advance
US capacity in infectious disease modeling by pioneering new meth-
odologies, studying key emerging disease threats, and training the next
generation of scientists (Box 4). RAPIDD departed from traditional
grant-based programs in its flexibility and concentration on working
group and workshop activities, and on developing research capacity. A
key success of RAPIDD since 2007 has been to promote collaborative
research and synergies between modeling groups beyond core partici-
pants of the program (Box 1).
3.2. Responses to ebola and Zika outbreaks
RAPIDD research has been at the forefront of responding to the
greatest infectious disease crises of recent years, particularly the 2013-
16 Ebola epidemic in West Africa and the Zika epidemic in the
Americas. Modeling work helped to identify key routes of Ebola
transmission and characterize effectiveness of intervention policies
(Team, Aylward et al. 2014, Camacho, Kucharski et al., 2015a, 2015b,
Kucharski, Camacho et al., 2015; Team, Agua-Agum et al. 2015). Fur-
ther work, in collaboration with WHO’s consortium for Ebola modeling,
identified risk factors for transmission including severe symptoms,
death, non-hospitalization, older age, and travel history (International
Ebola Response Team et al., 2016). Modeling work further demon-
strated the unintended consequences of the Ebola-associated healthcare
disruption on childhood immunization, and stressed the need to pro-
mote supplemental vaccination campaigns, particularly for measles
(Takahashi et al., 2015). Further, RAPIDD collaborators have developed
predictive maps of the spread of the Zika virus in the Americas, driven
by environmental conditions and population mobility (Bogoch, Brady
et al. 2016). Another RAPIDD modeling study analyzed factors shaping
the efficacy of screening air travelers for emerging pathogens, including
Ebola and MERS-coronavirus (Gostic et al., 2015). Taken together,
careful literature surveys of prior modeling work, in addition to pri-
mary research done by RAPIDD, form a substantial body of "case law"
for infectious disease modeling, which can be used as reference to un-
derstand and model outbreaks caused by new pathogens with similar
properties. As an important demonstration of this principle, prior
modeling work on dengue provided the groundwork for rapid devel-
opment of regional and global models for the spread of Zika virus
(Bogoch, Brady et al. 2016).
3.3. Four key research foci
During 2007–2015, RAPIDD functioned primarily via parallel
working groups focused on four areas identified as having important
research gaps: (i) methodological and data issues, (ii) zoonoses and
pathogen emergence, (iii) vector-borne infections, and (iv) disease dy-
namics in small mammals. The working groups conducted primary re-
search and led multi-disciplinary workshops on emerging research
frontiers (Box 1). Since 2007, RAPIDD organized 118 workshops across
a wide range of topics, with participation from thousands of scientists
and government employees globally. Workshops produced large-scale
reviews of the state-of-the-art of disease modeling in particular areas,
and opinion pieces discussing new frontiers of model-data synthesis
(Katz, Plowden et al. 2004; Buhnerkempe et al., 2015b; Frost, Pybus
et al. 2015; Gog, Pellis et al. 2015; Heesterbeek, Anderson et al. 2015;
Lloyd-Smith et al., 2015a,b; Metcalf et al., 2015a, b). Working group
members then pursued follow-up research to address the identified gaps
by developing new modeling approaches or new applications of models
to understudied but important diseases. The direct link between RA-
PIDD research and policy was ensured by periodic presentations to the
US White House scientific offices. Overall, since 2007, RAPIDD has
made substantive contributions across a remarkable range of public
health challenges (Box 2), from strategies to deploy current and future
vaccines to the unique role of bats as zoonotic reservoirs. While a
comprehensive review of the more than 1000 RAPIDD publications is
beyond the scope of this review (Fig. 3, Table 1), below we single out a
few achievements of the program.
3.4. Seminal reviews identify gaps in disease modeling
Many of the most important emerging disease threats involve zoo-
notic pathogens originating from animal reservoirs. By conducting a
seminal review of 442 published modeling studies of 85 zoonotic pa-
thogens, RAPIDD researchers identified critical areas in need of further
attention (Lloyd-Smith, George et al. 2009). The review highlighted the
marked predominance of studies of directly transmitted infections with
simple life cycle (e.g., influenza, SARS), over infections involving
multiple hosts with complex life cycles (vector-borne diseases, proto-
zoans, food-borne infections). It identified a dearth of modeling re-
search on looming threats including Ebola, chikungunya and yellow
fever viruses, which was regrettably prescient in light of subsequent
epidemics around the world (WHO, 2017). Crucially, the review noted
that very few studies linked dynamics across the animal-human inter-
face, where the defining process of zoonotic spillover occurs, and few
Box 4
: Training the next generation of scientists: RAPIDD post-doctoral fellows.
• Outstanding fellows handpicked and hired for 2 years minimum, and up to 4.• Comfortable prestigious fellowship, with independent and flexible funding for travel.• Strong impetus to work with the larger RAPIDD network of outstanding scientists, particularly by organizing workshops and working groups,
monthly Webex presentations, periodic policy-oriented seminars at the White House, and annual RAPIDD network meeting.• Post-doctoral fellows helped drive major collaborative reviews of modeling gaps (eg, zoonoses and emerging infections, vector-borne dis-
eases) — a superb bonding exercise leading to high-profile publications in their chosen fields.• Community of RAPIDD fellows learned from each other on topics ranging from communication skills to methodological issues.• Of the 13 RAPIDD fellows, 11 are in tenured or tenure-track academic positions, 1 works for the US government and 1 for a private company
(as of July 2018).
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models incorporated evolutionary processes. To address these gaps, the
zoonosis working group launched a series of methodological develop-
ments to link models across the animal-human interface, analyze the
stuttering chains of transmission that foreshadow emergence events,
and describe the evolutionary processes linked to pathogen emergence,
with key applications in monkeypox, MERS-Coronavirus and influenza
H5N1 and H7N9 viruses (Pepin et al., 2010; Rimoin, Mulembakani
et al. 2010; Blumberg and Lloyd-Smith, 2013a, b; Park, Loverdo et al.
2013; Blumberg, Enanoria et al. 2014; Chowell, Blumberg et al., 2014;
Kucharski and Althaus, 2015; Kucharski, Mills et al. 2015; Lloyd-Smith
et al., 2015a,b; Plowright, Parrish et al. 2017). Similarly, the RAPIDD
vector-borne disease working group’s review of 388 studies of mos-
quito-borne pathogen transmission determined that most models were
still primarily derived from mid-20th century methods pioneered by
Ross and Macdonald (Reiner, Perkins et al. 2013; Smith et al., 2014). In
response, the group developed more refined models to capture im-
portant features of mosquito-borne infections, including mosquito life
history, heterogeneous biting and fine-scale spatio-temporal variation
in transmission. Applying these methods to malaria and dengue high-
lighted the impact of incorporating realistic mosquito biology and
biting heterogeneities on control efforts (Stoddard, Forshey et al. 2013;
Perkins, Garcia et al. 2014; Reiner, Stoddard et al. 2014; Reiner, Le
Menach et al. 2015).
3.5. Disease forecasting
In recent years, a major focus of RAPIDD research has been in-
fectious disease forecasting, responding to a rising need in the public
health community, particularly for influenza and emerging infections
(Shaman, Karspeck et al. 2013; Yang, Cowling et al. 2015; Yang et al.,
2015a; Yang, Olson et al. 2016). In addition to RAPIDD’s work on
evaluating the impact of interventions in the midst of the West African
Ebola epidemic, RAPIDD launched an after-the-fact forecasting chal-
lenge using synthetic epidemiological data sets to assess model per-
formances in a controlled environment (Merler, Ajelli et al. 2017;
Viboud et al., 2017a, b). This unprecedented group effort revealed that
the most accurate disease forecasts stemmed from ensemble predictions
combining outputs from different models, since even the best models
have weaknesses, and that prediction accuracy does not scale with
model complexity. The forecasting challenge also strengthened com-
munication and collaboration between modeling groups, laying the
foundation for more effective response for the next public health crisis
(Viboud et al., 2017a, 2017b).
Influenza forecasting represents an area of rich synergy between the
RAPIDD and MISMS programs. A major aim of ongoing influenza re-
search is to predict the emergence and trajectory of new seasonal
strains, and hence improve the imperfect semi-annual vaccine strain
selection process. Forecasting work in this area was greatly enhanced
by a 2016 workshop, organized in collaboration with WHO, that
highlighted the need for better flow of genetic and antigenic informa-
tion from public health agencies to the institutions and mathematical
modelers to improve prediction accuracy and horizon (Morris, Gostic
et al. 2017). Further, RAPIDD and MISMS collaborators were the first to
analyze the potential benefits of broadly cross-protective influenza
vaccination programs (Arinaminpathy, Ratmann et al. 2012;
Subramanian, Graham et al. 2016). This is a particularly fruitful area of
overlap between RAPIDD and MISMS, as universal influenza vaccine
candidates enter pre-clinical trials, and an ideal opportunity to in-
tegrate network members’ expertise on relevant evolutionary and im-
munological concepts with the global source-sink dynamics so unique
to influenza (Gostic, Ambrose et al. 2016; Russell, Jones et al. 2008).
3.6. Cross-cutting research areas
Although the four RAPIDD working groups had separate areas of
focus, several synergistic themes rapidly emerged (Box 5). One domi-
nant theme was the spatiotemporal dynamics of pathogens, encom-
passing major strides in spatial dynamics and mapping of vector-borne
infections, a broad effort to advance data-driven models for foot-and-
mouth disease in the US and abroad, and cutting-edge syntheses of
novel and traditional data streams informing human demographics and
mobility to produce a new generation of spatio-temporal epidemic
models. Another major RAPIDD theme on pathogen evolution – en-
tailing phylodynamics, virulence evolution, host jumps and drug re-
sistance – has generated methodological breakthroughs and important
applications to influenza, dengue, malaria, and more. Focused work-
shops re-examined current thinking on optimal drug treatment to
minimize resistance evolution (Read, Day et al. 2011; Kouyos, Metcalf
et al. 2014), and the potential to predict influenza pandemic risk from
viral sequence data (Russell, Kasson et al. 2014; Lipsitch, Barclay et al.
2016).
Fig. 3. Time trends in RAPIDD and MISMS citations. Citations as provided for
the period 2007–2017; full 2018 data unavailable at the time of this writing
(data collection performed on July 1, 2018).
Table 1
Bibliometric analysis of the RAPIDD and MISMS programs. RAPIDD publica-
tions are based on any mention of the RAPIDD program in acknowledgments;
this includes fellows and faculty funded by RAPIDD and/or participation to
RAPIDD workshops that led to publications. MISMS publications are based on
influenza research articles published by staff of the Fogarty International
Center, as listed in affiliations. Data collection performed on July 1, 2018.
Bibliometric Indicator RAPIDD MISMS
No. of articles 1,002 433
No. of citations 54,684 22,826
Median citation count per article 29.0 23.0
Cost per citation 312$ 140$
Cost per article 17,500$ 7,390$
H-index 106 79
Joint publications with collaborators from LMIC 290 (29.0%) 116 (26.8%)
LMIC: ow and middle income countries.
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3.7. Future focus of RAPIDD
Since 2007 RAPIDD has advanced the methods and applications of
data-driven modeling of infectious diseases, with a clear focus on
policy-relevant research, and has fostered a new generation of talented
researchers in this field (Box 4). The program’s remarkable success
arises from strong collaborations developed among the many partici-
pants over the years, its flexibility and agility in convening workshops
on emerging research frontiers, and from providing freedom and un-
paralleled networking opportunities for talented post-doctoral scien-
tists. Looking forward, pending availability of funds, RAPIDD will
continue its research emphases on emerging infections and vector-
borne diseases, while growing new areas of focus on topical challenges
such as on modeling the dynamics of anti-microbial resistance, and
predicting the impact of next-generation vaccines such as for re-
spiratory syncytial virus, malaria, typhoid, dengue, and the universal
influenza vaccine.
4. Discussion
The Fogarty-led MISMS and RAPIDD programs have been catalysts
in advancing state-of-the-art global infectious disease modeling and
training with tangible impacts in building capacity globally and guiding
policies, such as defining age priority groups for epidemic and pan-
demic influenza vaccines, addressing optimal delivery of influenza
vaccines in tropical and low-income countries, and highlighting gaps in
measles vaccine coverage following the Ebola outbreak in West Africa.
In addition to influencing policy, a major success of the MISMS and
RAPIDD programs is reflected by the outstanding professional trajec-
tories of their alumni, domestically and internationally, and the ex-
cellence and international scope of their publications (Table 1, Box 4).
Of the more than 1400 publications of the MISMS and RAPIDD pro-
grams, which have been cited over 50,000 times, 28% include authors
from LMICs. Many of the RAPIDD and MISMS trainees and collabora-
tors are now established as senior researchers.
Both programs rely on global multi-disciplinary networks to identify
and address research questions at the forefront of infectious disease
transmission and evolution. Both programs build off the “big data”
revolution that provides increasingly detailed and abundant informa-
tion on disease patterns and host behavior, leveraging a surge of pa-
thogen genetic sequence data, exquisitely detailed epidemiological in-
formation derived from digital and social media, and human mobility
and demographic proxies derived from mobile phones or remote sen-
sing. New methodological approaches are needed to handle such a vast
and diverse amount of information. Further, both programs have long
histories of promoting data sharing and development of publicly
available methodological tools, with key contributions to the Influenza
Genome Sequencing Program and Database, the BEAST package for
phylogenetic and associated analyses, and development of new trans-
mission modeling packages (POMP, TSIR) and spatial analysis software
(Epipoi) (Alonso and McCormick, 2012; Becker and Morris, 2016; King,
2018)
The MISMS and RAPIDD programs are also well connected with
parallel efforts at NIH and CDC and in the broader scientific commu-
nity. For instance, within NIH, there are strong synergies between
RAPIDD and MIDAS, a funding program in infectious disease modeling
managed by the National Institute for General Medical Sciences, and
between MISMS and the Centers of Excellence in Influenza Research
and Surveillance (CEIRS), funded by the National Institute of Allergy
and Infectious Diseases. In parallel, there are strong ties between
RAPIDD and MISMS and the CDC’s influenza division, involving joint
workshops, forecasting challenges (e.g., (Merler, Ajelli et al. 2017;
Viboud et al., 2017a, 2017b)) and post-doctoral exchanges. Further,
there is a tight link between MISMS and RAPIDD and national and
global public health agencies, with regular participation of collabora-
tors in the White House pandemic preparedness working group, US
government modeling coordination groups, and WHO modeling groups.
Several of the MISMS workshops have been co-organized with, and in
support of, foreign government agencies (Fig. 1), while many interna-
tional government representatives have taken part in MISMS and RA-
PIDD workshops.
Despite these successes, some challenges are worth noting. The most
Box 5
Key aspects of diseases dynamics investigated by RAPIDD.
1 Spatial dynamics, mobility, and disease incidence mapping (Nelson et al., 2007; Russell, Jones et al. 2008; Bharti, Tatem et al. 2011;
Nelson, Lemey et al. 2011; Wesolowski, Eagle et al. 2012; Bhatt, Gething et al. 2013; Stoddard, Forshey et al. 2013; Viboud, Nelson et al.
2013; Gog, Ballesteros et al. 2014; Perkins, Garcia et al. 2014; Reiner, Stoddard et al. 2014; Nelson, Viboud et al. 2015; Wesolowski et al.,
2016a; Charu, Zeger et al. 2017)
2 Integration of novel data-streams, including social and behavioral sciences (Gog, Ballesteros et al. 2014; Bansal, Chowell et al. 2016;
Simonsen et al., 2016)
3 Eradication and elimination end-game, persistence, and vaccine refusal (Klepac, Funk et al. 2015).
4 New modeling approaches: statistical fitting algorithms, disease and strain forecasting, and next-generation models for vector-borne diseases
(He, Ionides et al. 2010; Reiner, Perkins et al. 2013; Shaman, Karspeck et al. 2013; Perkins, Garcia et al. 2014; Reiner, Stoddard et al. 2014;
Shaman, Yang et al. 2014, Smith, Perkins et al., 2014; Chretien, Riley et al. 2015; Reiner, Le Menach et al. 2015; Yang et al., 2015b; Becker
and Morris, 2016; Yang, Olson et al. 2016; King, 2018)
5 Inference of transmission dynamics from pathogen sequence data (Rasmussen, Volz et al. 2014; Biek, Pybus et al. 2015; Gog, Pellis et al.
2015).
6 Evolution of virulence, adaptation to new host species, and drug resistance (Day, Andre et al. 2006; Pepin, Lass et al. 2010; Read, Day et al.
2011; Kerr, Ghedin et al. 2012; Huijben, Bell et al. 2013; Kouyos, Metcalf et al. 2014)
7 Animal-human interface (Lloyd-Smith, George et al. 2009; Pepin, Lass et al. 2010; Rimoin, Mulembakani et al. 2010; Blumberg and Lloyd-
Smith, 2013a, 2013)
8 Subcritical outbreak dynamics and pandemic risk assessment (Blumberg and Lloyd-Smith, 2013a, 2013; Blumberg, Enanoria et al. 2014;
Chowell, Blumberg et al., 2014; Russell, Kasson et al. 2014; Kucharski and Althaus, 2015; Kucharski, Mills et al. 2015; Gostic, Ambrose
et al. 2016; Lipsitch, Barclay et al. 2016)
9 Inference of disease dynamics and exposure history from serology (Lessler, Riley et al. 2012; Gostic, Ambrose et al. 2016; Pepin, Kay et al.
2017)
10 Disease transmission in agricultural settings including poultry and aquaculture (Pepin, Lloyd-Smith et al. 2013; Read, Baigent et al. 2015;
Kennedy, Kurath et al. 2016)
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problematic is the lack of sustainable long-term funding for these pro-
grams more than 10 years after they were created, even though their
combined annual costs are under 2M$, which is negligible relative to
the costs of public health crises (see (Office of Science, 2016; World
Bank and Ecohealth Alliance, 2018) for a discussion of the value of
infectious disease preparedness and modeling). It is worth nothing
however that the low cost of computational modeling does not include
funding for generation of biomedical, epidemiological and surveillance
data, which are essential to support modeling work. And with their
extended duration and distributed network structure, the RAPIDD and
MISMS programs fall outside standard funding streams, despite their
extraordinary efficiency in propelling leading-edge science and ad-
dressing problems of national interest (Box 2). As the Ebola and Zika
outbreaks clearly demonstrate, infectious disease threats are not in re-
treat Advances in multi-pathogen diagnostics and sequencing will fa-
cilitate real-time molecular epidemiology during future outbreaks, but
will require people on the ground and international partners who can
rapidly interpret large amounts of data. Development of new vaccines
(e.g., respiratory syncytial virus, universal influenza) and the growing
challenge of anti-microbial resistance will require improved models to
optimize public health policies and understand pathogen evolutionary
responses.
In conclusion, the MISMS and RAPIDD programs illustrate the
power of scientific diplomacy and collaborative research networks,
with demonstrable successes in improving research and control of in-
fectious diseases. We see no shortage of policy-relevant research themes
for these networks to explore, including the emergence of new threats
at the animal-human interface, microbial interactions within and be-
tween hosts, integration of traditional and novel data streams into ever
more sophisticated models, short- and long-term disease forecasts,
projections of the impact of novel vaccines, and anti-microbial re-
sistance. Fogarty-led disease modeling programs will continue to
strengthen capacity in LMICs for outbreak analysis, and in turn help
control emerging infectious disease threats domestically and inter-
nationally.
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